| DC Field | Value | Language |
|---|
| dc.contributor.author | Buzov, A. A. | - |
| dc.contributor.author | Kulikov, A. L. | - |
| dc.contributor.author | Avtina, T. V. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.contributor.author | Osipova, O. A. | - |
| dc.date.accessioned | 2022-04-26T07:19:41Z | - |
| dc.date.available | 2022-04-26T07:19:41Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | Development and validation of methods of quantitative determination of the new antidiabetic drug in the blood plasma of rats by high performance liquid chromatography with mass spectrometric detection / A.A. Buzov [et al.] // Research Result: Pharmacology and Clinical Pharmacology. - 2016. - Vol. 2, № 1(2).- P. 52-57. - Doi: 10.18413/2313-8971-2016-2-1-52-57. - Refer.: p. 57. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46351 | - |
| dc.description.abstract | We developed a method of quantification of the new antidiabetic drug 3-(1h-benzimidazole-2-yl)-1,2,2-trimethyl-cyclopentane-carbonic acid (c7070) in the blood plasma of rats by high-performance liquid chromatography with mass-spectrometric detection | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | antidiabetic agent | ru |
| dc.subject | the blood plasma of rats | ru |
| dc.subject | high-performance liquid chromatography | ru |
| dc.subject | mass spectrometric detection | ru |
| dc.subject | validation | ru |
| dc.title | Development and validation of methods of quantitative determination of the new antidiabetic drug in the blood plasma of rats by high performance liquid chromatography with mass spectrometric detection | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 2, № 1
|
